Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level
Valérie Boige, Julien Taïeb, Mohamed Hebbar, David Malka, Thierry Debaere, Laurent Hannoun, Emmanuelle Magherini, Dominique Mignard, Thierry Poynard, Michel Ducreux
Research output: Contribution to journal › Article › peer-review
63Scopus
citations
Fingerprint
Dive into the research topics of 'Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level'. Together they form a unique fingerprint.